Prime Medicine Inc (PRME)

Cost of Revenue

$45.85M

TTM · Period ending: · USD

PRME logo

PRME Cost of Revenue

Latest reported$45.85M
PRME TTM Cost of Revenue ($6.99M → $45.85M)
High-resolution chart · PNG

PRME cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Prime Medicine Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
45,846,000
47,710,000
45,854,000
45,854,000
1,864,000
0
1,315,000
1,315,000
1,315,000
1,315,000
0
0
0
0
0
0
0
1,162,000
5,728,000
6,987,000
6,987,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.